Abstract: The disclosure provides a method of active immunotherapy for a cancer patient, comprising administering vaccines against Globo series antigens (i.e., Globo H, SSEA-3 and SSEA-4). Specifically, the method comprises administering Globo H-CRM197 (OBI-833/821) in patients with cancer. The disclosure also provides a method of selecting a cancer patient who is suitable as treatment candidate for immunotherapy. Exemplary immune response can be characterized by reduction of the severity of disease, including but not limited to, prevention of disease, delay in onset of disease, decreased severity of symptoms, decreased morbidity and delayed mortality.

Abstract: A semiconductor device includes a magnetic tunneling junction (MTJ) on a substrate, a spacer adjacent to the MTJ, a liner adjacent to the spacer, and a first metal interconnection on the MTJ. Preferably, the first metal interconnection includes protrusions adjacent to two sides of the MTJ and a bottom surface of the protrusions contact the liner directly.

Abstract: A semiconductor device includes a magnetic tunneling junction (MTJ) on a substrate, a first spacer on one side of the of the MTJ, a second spacer on another side of the MTJ, a first metal interconnection on the MTJ, and a liner adjacent to the first spacer, the second spacer, and the first metal interconnection. Preferably, each of a top surface of the MTJ and a bottom surface of the first metal interconnection includes a planar surface and two sidewalls of the first metal interconnection are aligned with two sidewalls of the MTJ.

Abstract: A semiconductor device includes a magnetic tunneling junction (MTJ) on a substrate, a first spacer on one side of the of the MTJ, a second spacer on another side of the MTJ, a first metal interconnection on the MTJ, and a liner adjacent to the first spacer, the second spacer, and the first metal interconnection. Preferably, each of a top surface of the MTJ and a bottom surface of the first metal interconnection includes a planar surface and two sidewalls of the first metal interconnection are aligned with two sidewalls of the MTJ.

Abstract: The extract of Huangqi (Astragalus membranaceus) is a drug or composition with multiple effects. It is not only acting as an inhibitor of viral infection of host cells, but also has the emerging potential to inhibit viral replication and cytokine storm by mediating miRNA expression.

Abstract: A use of pharmaceutical composition for enhancing cancer treatment includes an Astragalus membranaceus extract and a mannose. The pharmaceutical composition can effectively enhance the effectiveness of chemotherapy drugs, thereby reducing cancer cell viability, and for drug resistant cancers. In addition, the pharmaceutical composition can also inhibit the growth of tumor cells.

Abstract: A functionalized MWCNT complex structure containing SiO2@EDAS nano-particles and Ag@Citrate nano-molecules and of high moisturization and sterilization includes a functionalized MWCNT; carbon atoms of a benzene of the functionalized MWCNT being combined with other functional groups containing COOH, OH and SO; a plurality of SiO2@EDAS nano-particles which are formed by modifying N-[3-(2-Aminoethylamino) propyl] trimethoxysilane (EDAS) on SiO2 nano-particles; the adhering layer further containing a plurality of Ag@Citrate nano-molecules. Therefore, since the functionalized MWCNTs 10 contains both the SiO2@EDAS nano-particles 21 and the Ag@Citrate nano-molecules 22 and thus it has the functions of the moisturization and sterilization.